Acting Deputy Controller, Public Affairs at California State Controller's Office
Employing Organization
Team
Decision makers at California State Controller's Office
Acting Chief Information Officer
Acting Chief Operating Officer
Assistant Press Secretary
Budget Officer
Key decision makers in the same organization
Organization Signals
Board meetings, strategic plans, and buyer signals from Bismarck Obando’s organization
The panel discussed the work plan, reviewed current legislation and litigation, and deliberated on emerging practices for actuarial assumptions. They also scheduled future meetings and added the adoption of the PEPRA compensation limit letter to the agenda for the next meeting.
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Verified emails & phones
Accuracy-guaranteed data
Job-change & title updates
Never lose a contact
The Panel held elections for the Chair and Vice Chair positions. Discussion regarding the work plan resulted in the approval of updates to due dates for work plan items and the removal of one item from the plan. The Panel reviewed exposure drafts for ASOP 41 and ASOP 6, determining no comments were necessary. Additionally, the Panel decided to resend a letter concerning AB 1383 and engaged in a discussion regarding emerging practices for actuarial assumptions.
The meeting included the adoption of minutes from a previous meeting, a presentation of the 2022/23 independent financial audit by Macias Gini & O'Connell, LLP, and the State Controller's audit review report. Discussion also covered the California Institute for Regenerative Medicine's (CIRM) strategic plan, program changes, clinical trials, grants awarded, and future plans. An update on CIRM's performance audit was introduced but the transcript concluded before its completion. The meeting concluded with public comment and board member comments.
The meeting will include a presentation of the 2022/23 Independent Financial Audit by Macias Gini & O'Connell, LLP (MGO), along with the State Controller's Audit Review Reports for 2022/23. Updates will be provided on the California Institute for Regenerative Medicine (CIRM) Strategic Plan, program changes, clinical trials, grants awarded, and CIRM's future. An update on CIRM's Performance Audit will also be given. Public comment and board member comments will be included.
Extracted from official board minutes, strategic plans, and video transcripts.
Organization signals
Board meetings and buying signals
Salesforce & HubSpot sync
Native two-way integration
